BioShin Pharmaceuticals

BioShin is a development and commercialization company focused on advancing therapies for which there are currently no adequate treatment options. Our current clinical programs span a range of innovative, late-stage product candidates targeting neurological diseases. Bioshin is the Asia-Pacific subsidiary of Biohaven Pharmaceuticals.